Cullinan Therapeutics’ $280 Million Private Placement

Leila Ahmed North America Legal Chronicle
Tagged:

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Foresite Capital in the transaction.Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company, announced…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here